Volume 8, Number 4—April 2002
Research
Outcomes of Treated Human Granulocytic Ehrlichiosis Cases
Alan H. Ramsey*†
, Edward A. Belongia‡, Craig M. Gale‡, and Jeffrey P. Davis†
, Edward A. Belongia‡, Craig M. Gale‡, and Jeffrey P. Davis†
Table 1
Recurrent or continuous symptoms experienced during the preceding 12 months by human granulocytic ehrlichiosis patients and controls, Wisconsin, 1999
| Symptom | Patients (N=85) number (%) | Controls (N=102) number (%) | OR | 95% CI |
|---|---|---|---|---|
| Fevers | 12 (14.1) | 3 (2.9) | 5.4 | 1.7-24.4 |
| Shaking chills | 16 (18.8) | 5 (4.9) | 4.5 | 1.7-14.3 |
| Sweats | 31 (36.5) | 16 (15.7) | 3.1 | 1.6-6.3 |
| Fatigue | 47 (55.3) | 38 (37.3) | 2.1 | 1.2-3.7 |
| Confusion | 16 (18.8) | 12 (11.8) | 1.7 | 0.8-4.0 |
| Muscle weakness | 27 (31.8) | 30 (29.4) | 1.1 | 0.6-2.1 |
| Headache | 21 (24.7) | 13 (12.8) | 1.1 | 0.7-1.9 |
| Muscle aches | 40 (47.1) | 44 (43.1) | 1.0 | 0.7-1.5 |
| Joint pains | 50 (58.8) | 54 (52.9) | 0.9 | 0.6-1.2 |
| Nausea | 14 (16.5) | 15 (14.7) | 0.8 | 0.5-1.4 |
OR = odds ratio; 95% CI = 95% confidence interval.
Page created: July 15, 2010
Page updated: July 15, 2010
Page reviewed: July 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.